|Day's Range||26.68 - 26.87|
|52 Week Range||19.67 - 26.97|
|PE Ratio (TTM)||85.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Companies are winning over the SEC in their use of unofficial accounting figures, a year after a crackdown on the practice.
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. Will it continue?
Boston Scientific Corporation (BSX) recently completed the acquisition of Switzerland-based Symetis SA.